Calcady™
Home / Fitness / HbA1c to eAG (Estimated Average Glucose) Converter

HbA1c to eAG (Estimated Average Glucose) Converter

Instantly translate your A1C blood test percentage into an estimated average daily glucose reading in mg/dL or mmol/L using the ADA validated formula.

HbA1c to eAG Converter

Instantly translate your A1C blood test percentage into an estimated average daily glucose reading using the ADA formula.

01 — HbA1c Value (%)

Normal range: 4.0–5.6%. ADA target for most diabetics: <7.0%.

Above ADA Target
154
mg/dL
Also: 8.56 mmol/L (international)
02 — Complete Breakdown
HbA1c
7.0%
eAG (mg/dL)
154
eAG (mmol/L)
8.56
Risk Category
Above
HbA1c input7.0%
ADA formula (mg/dL)(28.7 × 7.0) − 46.7 = 154.2 mg/dL
eAG (mg/dL)154.2 mg/dL
eAG (mmol/L)154.2 ÷ 18.015 = 8.56 mmol/L
Approx. 3-month range131–177 mg/dL
ADA classificationAbove ADA Target
ADA Reference Table
HbA1ceAG (mg/dL)eAG (mmol/L)
5.0%975.4
5.7%1176.5
6.0%1257.0
6.5%1407.8
7.0%1548.6
7.5%1699.4
8.0%18310.2
9.0%21211.7
10.0%24013.3
Summary: An HbA1c of 7.0% corresponds to an estimated average glucose (eAG) of 154 mg/dL (8.6 mmol/L) — Above ADA Target.
Practical Example

A patient's lab report shows HbA1c = 7.0%. ADA formula: (28.7 × 7.0) − 46.7 = 200.9 − 46.7 = 154 mg/dL eAG. International equivalent: 154 ÷ 18.015 = 8.6 mmol/L. The ADA target for most adults with Type 2 diabetes is HbA1c <7.0%, which corresponds to an average glucose below 154 mg/dL. Bringing HbA1c from 8.0% → 7.0% reduces the eAG from 183 mg/dL to 154 mg/dL — a 16% reduction in chronic average glucose exposure.

Email LinkText/SMSWhatsApp

What is HbA1c and eAG: How the ADA Formula Links A1C% to Daily Blood Sugar?

Translate your A1C blood test percentage into an estimated average daily glucose reading — understanding how a single percentage number represents 3 months of continuous blood sugar exposure.

Mathematical Foundation

ADA eAG Formula (mg/dL)
eAG (mg/dL)=(28.7×HbA1c%)−46.7eAG\ (mg/dL) = (28.7 \times HbA1c\%) - 46.7
28.728.7= The regression slope derived from the ADAG (A1C-Derived Average Glucose) study — a multi-center clinical study correlating continuous glucose monitoring data with concurrent A1C measurements.
−46.7-46.7= The regression intercept. Together, 28.7x − 46.7 is the best-fit linear model over 507 glucose readings per participant.
Unit Conversion
eAG (mmol/L)=eAG (mg/dL)18.015eAG\ (mmol/L) = \frac{eAG\ (mg/dL)}{18.015}
18.01518.015= Molecular weight of glucose (g/mol). Dividing mg/dL by 18.015 converts to SI units (mmol/L) used in Canada, EU, Australia, and most of the world outside the US.

Laws & Principles

  • HbA1c (glycated hemoglobin) reflects the average blood glucose over 2–3 months, weighted toward the most recent 30 days. It measures what percentage of hemoglobin molecules have glucose permanently attached.
  • ADA Clinical Targets (2024): General target for most adults with diabetes: HbA1c < 7.0% (eAG < 154 mg/dL). Older adults or those prone to hypoglycemia may target < 8.0% (eAG < 183 mg/dL). Pregnancy: < 6.0% (eAG < 126 mg/dL).
  • Conditions that falsify HbA1c: hemolytic anemia, iron deficiency anemia, sickle cell trait, recent blood transfusion, or high-dose vitamin C supplementation can all cause HbA1c readings that don't accurately reflect average glucose. In these cases, fructosamine tests are used instead.
  • The eAG is an estimate — individual glucose variability means the actual average may differ. A patient with significant glucose swings (high peaks and lows) may have the same A1C as a patient with a flat, stable glucose curve.
  • Interpretation gap: patients often ask what their A1C 'means in terms of blood sugar.' The eAG bridges this gap — telling a patient 'your A1C of 7% is like averaging 154 mg/dL all day' is more intuitive than a raw percentage.

Step-by-Step Example Walkthrough

" A patient's quarterly lab shows HbA1c = 8.5%. Their doctor's target is <7.0%. "

  1. eAG at 8.5%: (28.7 × 8.5) − 46.7 = 243.95 − 46.7 = 197.3 mg/dL.
  2. eAG at target 7.0%: (28.7 × 7.0) − 46.7 = 200.9 − 46.7 = 154.2 mg/dL.
  3. Gap to close: 197.3 − 154.2 = 43.1 mg/dL average reduction needed.
  4. International: 197.3 / 18.015 = 10.9 mmol/L current; target = 8.6 mmol/L.
Final Result: Reducing average daily glucose by ~43 mg/dL across 90 days (requiring diet, exercise, or medication changes) would bring HbA1c from 8.5% to 7.0%. Each 1% reduction in HbA1c is associated with a ~21% reduction in diabetes-related complications (UKPDS study).

Quick Answer: How does the HbA1c to eAG Converter work?

Enter your HbA1c percentage from your blood work and the converter instantly applies the ADA/ADAG regression formula — eAG (mg/dL) = (28.7 × A1C%) − 46.7 — to translate your 3-month glycated hemoglobin reading into an estimated daily average glucose in mg/dL or mmol/L. Results update in real time as you type, with color-coded risk classification mapped to ADA clinical targets.

The ADA eAG Conversion Formula

eAG in US Units

eAG (mg/dL) = (28.7 × HbA1c%) − 46.7

eAG in SI Units

eAG (mmol/L) = eAG (mg/dL) ÷ 18.015

This linear model was derived from the 2008 ADAG study (Nathan et al., Diabetes Care) which correlated approximately 2,700 continuous glucose monitoring readings per participant with simultaneous A1C tests across 507 participants from 10 international centers. The correlation coefficient was r = 0.92, making this the gold-standard conversion recommended by the ADA, EASD, and IDF.

Clinical Scenarios

✓ On-Target Management

Type 2 diabetic patient on metformin with lifestyle intervention

  1. HbA1c: 6.4%
  2. eAG: (28.7 × 6.4) − 46.7 = 137.0 mg/dL
  3. mmol/L: 137.0 ÷ 18.015 = 7.6 mmol/L

→ Well below the ADA 7.0% target. This patient's average glucose of 137 mg/dL indicates effective blood sugar control with minimal risk of micro- and macrovascular complications.

✗ Uncontrolled — High Complication Risk

Type 2 diabetic with poor medication adherence

  1. HbA1c: 10.2%
  2. eAG: (28.7 × 10.2) − 46.7 = 246.0 mg/dL
  3. mmol/L: 246.0 ÷ 18.015 = 13.7 mmol/L

→ Averaging 246 mg/dL means persistent hyperglycemia. UKPDS data shows each 1% A1C above 7% increases microvascular complication risk by ~37%. Urgent medication adjustment and dietary review recommended.

HbA1c to eAG Quick-Reference Table

HbA1c (%) eAG (mg/dL) eAG (mmol/L)
5.0 97 5.4
5.7 117 6.5
6.5 140 7.8
7.0 154 8.6
8.0 183 10.2
10.0 240 13.3
12.0 298 16.5

Pro Tips & Clinical Insights

Do This

  • ✓Use eAG for patient communication. Telling a patient "your average blood sugar was 197 mg/dL" is more actionable than "your A1C is 8.5%." The eAG maps directly to what they see on their home glucose meter.
  • ✓Consider time-in-range alongside A1C. Two patients with identical A1C of 7.0% can have wildly different glucose profiles — one flat at 154, another swinging 60–260. CGM data (time-in-range 70–180 mg/dL) adds context the A1C alone cannot provide.

Avoid This

  • ✗Don't rely on A1C alone if hemoglobin is abnormal. Iron deficiency falsely elevates A1C. Hemolytic anemia, sickle cell trait, and recent blood transfusions falsely lower it. In these populations, fructosamine (2–3 week window) or glycated albumin should replace A1C for monitoring.
  • ✗Don't compare fingerstick readings directly to eAG. A single fasting glucose is a point-in-time snapshot. The eAG represents the 90-day continuous average including post-meal spikes, overnight levels, and dawn phenomenon — they are different metrics measuring different things.

Frequently Asked Questions

What is the difference between HbA1c and eAG?

HbA1c is a lab measurement showing what percentage of your hemoglobin has glucose permanently bonded to it — reflecting roughly 2–3 months of blood sugar exposure. The eAG (estimated Average Glucose) is a mathematical translation of that percentage into a daily glucose reading (mg/dL or mmol/L) using the ADA regression formula. They represent the same underlying data in different units — similar to how Celsius and Fahrenheit both measure temperature.

Why might my home glucose meter readings not match my eAG?

Home meter readings capture single moments in time — usually fasting or pre-meal. The eAG reflects a true 24-hour average over 90 days, including post-meal spikes, overnight lows, and dawn phenomenon. If you only test fasting glucose (typically the lowest reading of the day), your meter average will appear lower than your actual all-day average. CGM (continuous glucose monitoring) data correlates much more closely with eAG because it captures the full 24-hour cycle.

Can conditions other than diabetes affect my A1C reading?

Yes. Any condition that changes red blood cell lifespan will distort A1C. Iron deficiency anemia slows red cell turnover, causing glucose to accumulate on hemoglobin longer and falsely raising A1C. Hemolytic anemia and sickle cell trait accelerate red cell destruction, falsely lowering A1C. Recent blood transfusions dilute the glycated hemoglobin pool. High-dose vitamin C or E supplementation can also interfere with the immunoassay. In these cases, clinicians use fructosamine or glycated albumin testing instead.

How much does each 1% reduction in HbA1c reduce complication risk?

The UK Prospective Diabetes Study (UKPDS) — the largest and longest diabetes clinical trial — showed that each 1% decrease in HbA1c reduces the risk of microvascular complications (retinopathy, nephropathy, neuropathy) by approximately 37%, diabetes-related deaths by 21%, and heart attacks by 14%. This relationship is continuous — meaning reducing from 9% to 8% provides as much relative benefit as reducing from 8% to 7%. Even moving from 10% to 9.5% yields measurable clinical benefit.

Blood Sugar & Metabolic Health Tools